- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 7, 2024 | 51.52M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $48.53M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $37.71M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $11.39M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $14.03M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $23.22M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $26.46M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $218.79M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $207.41M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $237.54M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $252.15M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 45.81M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 45.79M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $721K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$27.91M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $217.81M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $230.17M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $246.03M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.38 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.80 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.38 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.80 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $6.28M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $12.69M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $13.84M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $28.92M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$17.44M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$36.56M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$19.13M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$20.12M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$41.6M |